Osteoarthritis Trial, Recruiting (NCT04688593)

Osteoarthritis Trial, Recruiting NCT04688593 Sponsor: Waldemar Link GmbH & Co. KG Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT04688593 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are having a specific hip replacement device (the MobileLink acetabular cup system and a femoral stem, both made by Waldemar Link) implanted during their surgery
People who are 18 years of age or older
People who have read, understood, and signed the consent form agreeing to take part in the study

Who may not be able to join:

People who are having revision surgery (a repeat or corrective hip replacement procedure, rather than a first-time implant)
People with a Body Mass Index (BMI) of 40 or higher (a measure of body weight relative to height)
People who are not expected to be able to understand the study and what it involves
People who are not expected to be able to follow the treatment plan and attend the required follow-up appointments
People who are pregnant or currently breastfeeding
People who are currently in prison

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +494053995673

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04688593

Sponsor: Waldemar Link GmbH & Co. KG

Phase: Not Applicable

Status: Recruiting

Condition: Osteoarthritis

Trial contact: +494053995673

More information: https://clinicaltrials.gov/study/NCT04688593

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are having a specific hip replacement device (the MobileLink acetabular cup system and a femoral stem, both made by Waldemar Link) implanted during their surgery
People who are 18 years of age or older
People who have read, understood, and signed the consent form agreeing to take part in the study

Who may not be able to join:

People who are having revision surgery (a repeat or corrective hip replacement procedure, rather than a first-time implant)
People with a Body Mass Index (BMI) of 40 or higher (a measure of body weight relative to height)
People who are not expected to be able to understand the study and what it involves
People who are not expected to be able to follow the treatment plan and attend the required follow-up appointments
People who are pregnant or currently breastfeeding
People who are currently in prison

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Waldemar Link GmbH & Co. KG

Registry

ClinicalTrials.gov

Start date

4 May 2021

Est. completion

1 January 2036

Where this trial is recruiting

🇩🇪 Germany 🇬🇧 United Kingdom

Primary endpoints

Survival rate of the complete MobileLink hip prosthesis system with revision for any reason as the endpoint,

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov